Next-Generation Medical Sensors: Innovation at the Frontier of Healthcare
When
May 5, 2026
5:30 - 7:30 PM
Where
Online or at the
CIC Cambridge - 1 Broadway (5th Floor Havana Room)
Cambridge,
MA
02142
Join industry leaders, innovators, and legal experts for a forward-looking in-person and online panel discussion exploring the rapidly evolving landscape of medical sensor technologies. Sponsored by Hamilton Brook Smith Reynolds and the Medical Development Group of Boston, this session brings together perspectives from academia, startups, and industry to examine how cutting-edge sensors are transforming diagnostics, monitoring, and personalized medicine.
We will explore breakthroughs in biosensors, wearable devices, and optical sensing platforms, along with the growing role of artificial intelligence in enhancing signal processing, predictive analytics, and real-time clinical decision-making. The discussion will also address key challenges in protecting innovation, including patent eligibility, software-driven sensor claims, and global IP strategies.
Designed for startup companies, university technology transfer officers, venture capital firms, and medical device companies, this webcast will provide practical insights into:
- Emerging medical sensor technologies and commercialization pathways
- AI-driven sensor innovation and data interpretation
- Patent strategies in medical sensing technologies
- Opportunities for collaboration between academia, industry, and investors
- Digital biomarkers and remote patient monitoring ecosystems
- Sensor fusion (combining multiple modalities for better diagnostics)
- Integration with telehealth and decentralized clinical trials
The session will conclude with a dynamic panel discussion and audience Q&A.
Speakers
Selim Ünlü
Distinguished Professor of Electrical & Computer Engineering, Biomedical Engineering, and Materials Science, Boston University
Selim Ünlü received the his Ph.D. (1992) degree from the University of Illinois at Urbana-Champaign, in electrical engineering. Since 1992, he has been a professor at Boston University. He is currently a Distinguished Professor of Engineering appointed in electrical and computer engineering, biomedical engineering, physics, materials science and engineering, and graduate medical sciences. He also serves as the CTO of IRIS Kinetics, a start-up company commercializing biosensing technology developed in his research laboratory at BU.
His current research interests are in the areas of nanophotonics and biophotonics focusing on development of biological detection and imaging techniques, particularly in high-throughput digital biosensors based on detection of individual biological nanoparticles, viruses, and single molecule counting.
Jonathan Hagyard
Senior Product Manager, Delsys
Jonathan Hagyard is a Senior Product Manager at Delsys, specializing in the application of electromyography (EMG) to advance the understanding of human movement. With a background in biomechanics and neuromuscular science, he works at the intersection of research, technology, and real-world application, helping translate complex EMG data into meaningful insights for human performance, rehabilitation, and engineering.
Jonathan is focused on improving how EMG is applied in both research and practice, with an emphasis on making complex neuromuscular data more interpretable and usable. His work supports the development of tools and workflows that enable clearer insight into muscle function, coordination, and control across a range of movement contexts. By working closely with researchers and practitioners, he contributes to bridging the gap between data collection and meaningful interpretation.
Avni Argun, Ph.D.
Chief Technology Officer at Giner Labs
Dr. Argun leads the development of electrochemical sensor technologies for healthcare and environmental applications at Giner Labs. Since joining Giner Labs, he has led biosensor programs spanning point-of-care diagnostics, blood electrolyte monitoring, noninvasive hormone and biomarker monitoring, multiplexed gene sensing, microbiome analysis, and wastewater-based detection. His work includes platforms for salivary biomarker monitoring and opioid metabolite detection, as well as gene sensor technologies for bacterial, fungal, and tumor mutation detection.
Dr. Argun trained at the University of Florida and MIT and has more than fifteen years of experience in electrochemistry, sensors, and materials science. He has authored over twenty research articles and is co-inventor on multiple U.S. patents related to biosensor systems and device design.
Alexander Adam
Shareholder Principal (Patent Attorney), Hamilton Brook Smith Reynolds
Alex specializes in drafting and prosecuting patent applications in the fields of computer systems, electronics, imaging software, control systems, mechanical devices, medical devices, telecommunications, and clean energy. He also has experience in patent litigation, due diligence, and providing invalidity and non-infringement opinions. Alex advises clients on U.S. and international patent strategy.